The public record for NCT07752381 identifies Parlay Wellness as sponsor and a commercial peptide gummy product as the intervention. Its brief summary says the gummies contain BPC-157. The structured enrollment field reports 40 actual participants, and the status says completed.
The annual-news event here is the registry’s first posting on 7 August 2026, not the beginning of a new trial that day. The record lists an actual start on 1 September 2025 and primary completion on 1 November 2025. Registration therefore follows the recorded conduct. This observation does not by itself establish a legal reporting violation; applicability and other facts have not been evaluated.
What the record does—and does not—report
The summary describes an eight-week study using inflammatory blood markers and participant questionnaires. Those descriptions establish what the sponsor registered, not what the product achieved. In our 29 October snapshot, the record has no posted results module. It does not give a clinical effect size, a comparative adverse-event estimate or evidence from which we can conclude improved recovery.
“No posted results” is scoped to this retrieved registry record. It does not prove that no paper, report or other disclosure exists elsewhere; a separate publication search and full-paper assessment remain needed. Nor does completed status independently confirm that every planned procedure took place as described.
Classification is not permission
The registry categorizes the intervention as a dietary supplement. That is a submitter-supplied database field—not an FDA classification ruling, an approval, a safety determination or permission to market BPC-157 in that form. A product’s format does not remove the need to assess its actual regulatory status, identity and claims.
For an annual report, keep product-specific evidence separate from a molecule-wide narrative. An orally consumed commercial gummy cannot be assumed equivalent to a planned injectable surgical-recovery intervention. A registry entry for either product does not validate the other, and a brand’s registered study is not a neutral endorsement of the brand.
Evidence record
Event date: 2026-08-07. Source review: 2026-10-29. Editorial publication: 2026-10-29. Original source links below retain their publication dates. These dates are not interchangeable. This is targeted source synthesis, not an exhaustive archive or a qualified clinical/legal review.
- ClinicalTrials.gov NCT07752381 · original record and history ↗
- ClinicalTrials.gov · government review and sponsor responsibilities ↗
Revision history
29 October 2026: authored from the public registry snapshot and separate screening ledger. No independent sponsor contact, regulatory-file verification or full-paper efficacy review performed. Report a proposed correction through Contact us; do not include patient data.